EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

RETRACTED: Myogenesis Effects of RGX365 to Improve Skeletal Muscle Atrophy

Hye-Jin Lee, Hui-Ji Choi, Sang-Ah Lee, Dong Hyuk Baek iD, Jong Beom Heo iD, Gyu Yong Song, Wonhwa Lee iD

Nutrients · 2023

DOI: 10.3390/nu15194307 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Nutrients, 2023. Verfasst von Hye-Jin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Agriculture, Food and Rural Affairs, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age-related skeletal muscle atrophy and weakness not only reduce the quality of life of those afflicted, but also worsen the prognosis of underlying diseases. We evaluated the effect of RGX365, a protopanaxatriol-type rare ginsenoside mixture, on improving skeletal muscle atrophy. We investigated the myogenic effect of RGX365 on mouse myoblast cells (C2C12) and dexamethasone (10 µM)-induced atrophy of differentiated C2C12. RGX365-treated myotube diameters and myosin heavy chain (MyHC) expression levels were analyzed using immunofluorescence. We evaluated the myogenic effects of RGX365 in aging sarcopenic mice. RGX365 increased myoblast differentiation and MyHC expression, and attenuated the muscle atrophy-inducing F-box (Atrogin-1) and muscle RING finger 1 (MuRF1) expression. Notably, one month of oral administration of RGX365 to 23-month-old sarcopenic mice improved muscle fiber size and the expression of skeletal muscle regeneration-associated molecules. In conclusion, rare ginsenosides, agonists of steroid receptors, can ameliorate skeletal muscle atrophy during long-term administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaMiceAnimalsQuality of LifeCell LineMuscular AtrophyMuscle, SkeletalMuscle Fibers, SkeletalMuscle Development

Stichwörter der Autor:innen

RGX365myogenesismyosin heavy chainrare ginsenosidessarcopenia

Autor:innen und Institutionen

  • Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.
  • Environmental Safety Group, Korea Institute of Science and Technology (KIST) Europe, 66123 Saarbruecken, Germany.
  • AREZ Co., Ltd., Daejeon 34036, Republic of Korea.

ORCID-Profile: Dong Hyuk Baek, Jong Beom Heo, Wonhwa Lee

Förderung

  • National Research Foundation of Korea
  • Ministry of Agriculture, Food and Rural Affairs
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry

Zitieren

APA

Lee, H. J., Choi, H. J., Lee, S. A., Baek, D. H., Heo, J. B., Song, G. Y., & Lee, W. (2023). RETRACTED: Myogenesis Effects of RGX365 to Improve Skeletal Muscle Atrophy. Nutrients. https://doi.org/10.3390/nu15194307

Vancouver

Lee HJ, Choi HJ, Lee SA, Baek DH, Heo JB, Song GY, et al. RETRACTED: Myogenesis Effects of RGX365 to Improve Skeletal Muscle Atrophy. Nutrients. 2023. doi:10.3390/nu15194307

BibTeX
@article{Lee2023,
  author = {Lee, Hye-Jin and Choi, Hui-Ji and Lee, Sang-Ah and Baek, Dong Hyuk and Heo, Jong Beom and Song, Gyu Yong and Lee, Wonhwa},
  title = {RETRACTED: Myogenesis Effects of RGX365 to Improve Skeletal Muscle Atrophy},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15194307}
}
Kostenlos starten →